These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1315 related items for PubMed ID: 16166455
1. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N. Clin Cancer Res; 2005 Sep 15; 11(18):6738-44. PubMed ID: 16166455 [Abstract] [Full Text] [Related]
2. Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells. Lev-Ari S, Strier L, Kazanov D, Elkayam O, Lichtenberg D, Caspi D, Arber N. Rheumatology (Oxford); 2006 Feb 15; 45(2):171-7. PubMed ID: 16249246 [Abstract] [Full Text] [Related]
3. Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase. Kim SH, Kim SH, Song YC, Song YS. Ann N Y Acad Sci; 2009 Aug 15; 1171():635-41. PubMed ID: 19723114 [Abstract] [Full Text] [Related]
4. Down-regulation of prostaglandin E2 by curcumin is correlated with inhibition of cell growth and induction of apoptosis in human colon carcinoma cell lines. Lev-Ari S, Maimon Y, Strier L, Kazanov D, Arber N. J Soc Integr Oncol; 2006 Aug 15; 4(1):21-6. PubMed ID: 16737669 [Abstract] [Full Text] [Related]
5. Growth inhibitory effect of celecoxib and rofecoxib on human colorectal carcinoma cell lines. Buecher B, Bouancheau D, Broquet A, Bezieau S, Denis MG, Bonnet C, Heymann MF, Jarry A, Galmiche JP, Blottière HM. Anticancer Res; 2005 Aug 15; 25(1A):225-33. PubMed ID: 15816542 [Abstract] [Full Text] [Related]
6. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines. Hashitani S, Urade M, Nishimura N, Maeda T, Takaoka K, Noguchi K, Sakurai K. Int J Oncol; 2003 Sep 15; 23(3):665-72. PubMed ID: 12888902 [Abstract] [Full Text] [Related]
7. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. Grösch S, Tegeder I, Niederberger E, Bräutigam L, Geisslinger G. FASEB J; 2001 Dec 15; 15(14):2742-4. PubMed ID: 11606477 [Abstract] [Full Text] [Related]
8. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib. Zhang GS, Liu DS, Dai CW, Li RJ. Am J Hematol; 2006 Apr 15; 81(4):242-55. PubMed ID: 16550520 [Abstract] [Full Text] [Related]
9. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells. Spinella F, Rosanò L, Di Castro V, Nicotra MR, Natali PG, Bagnato A. Clin Cancer Res; 2004 Jul 15; 10(14):4670-9. PubMed ID: 15269139 [Abstract] [Full Text] [Related]
10. Celecoxib and curcumin additively inhibit the growth of colorectal cancer in a rat model. Shpitz B, Giladi N, Sagiv E, Lev-Ari S, Liberman E, Kazanov D, Arber N. Digestion; 2006 Jul 15; 74(3-4):140-4. PubMed ID: 17228149 [Abstract] [Full Text] [Related]
11. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism. Patel MI, Subbaramaiah K, Du B, Chang M, Yang P, Newman RA, Cordon-Cardo C, Thaler HT, Dannenberg AJ. Clin Cancer Res; 2005 Mar 01; 11(5):1999-2007. PubMed ID: 15756026 [Abstract] [Full Text] [Related]
12. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer. Wang L, Chen W, Xie X, He Y, Bai X. Exp Oncol; 2008 Mar 01; 30(1):42-51. PubMed ID: 18438340 [Abstract] [Full Text] [Related]
13. The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer. Cianchi F, Cortesini C, Schiavone N, Perna F, Magnelli L, Fanti E, Bani D, Messerini L, Fabbroni V, Perigli G, Capaccioli S, Masini E. Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):6807-15. PubMed ID: 16203768 [Abstract] [Full Text] [Related]
14. Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells. Suh YJ, Chada S, McKenzie T, Liu Y, Swisher SG, Lucci A, Hunt KK. Surgery; 2005 Sep 01; 138(3):422-30. PubMed ID: 16213894 [Abstract] [Full Text] [Related]
15. [Effect of celecoxib on enhancing the chemotherapic sensitivity of hydroxyurea to K562 cells and its mechanism]. Liu DS, Zhang GS. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct 01; 29(5):495-9. PubMed ID: 16137030 [Abstract] [Full Text] [Related]
16. Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/extracellular signal-regulated kinase kinase, in recurrent respiratory papillomas. Wu R, Abramson AL, Shikowitz MJ, Dannenberg AJ, Steinberg BM. Clin Cancer Res; 2005 Sep 01; 11(17):6155-61. PubMed ID: 16144915 [Abstract] [Full Text] [Related]
17. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells. Cui W, Yu CH, Hu KQ. Clin Cancer Res; 2005 Nov 15; 11(22):8213-21. PubMed ID: 16299255 [Abstract] [Full Text] [Related]
18. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens. Swamy MV, Cooma I, Reddy BS, Rao CV. Int J Oncol; 2002 Apr 15; 20(4):753-9. PubMed ID: 11894121 [Abstract] [Full Text] [Related]
19. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis. Erickson BA, Longo WE, Panesar N, Mazuski JE, Kaminski DL. J Surg Res; 1999 Jan 15; 81(1):101-7. PubMed ID: 9889067 [Abstract] [Full Text] [Related]
20. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors. Zweifel BS, Davis TW, Ornberg RL, Masferrer JL. Cancer Res; 2002 Nov 15; 62(22):6706-11. PubMed ID: 12438270 [Abstract] [Full Text] [Related] Page: [Next] [New Search]